Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10237478 | 0.96 | CCNC (0.31) | CCNCCDK8DGAT1 | |
| SCHEMBL10237461 | 0.91 | CHEK1 (0.33) | CCNCCDK8DGAT1 | |
| SCHEMBL10237467 | 0.90 | DGAT1 (0.39) | CCNCCDK8DGAT1 | |
| SCHEMBL10237470 | 0.90 | DGAT1 (0.35) | CCNCCDK8DGAT1 | |
| SCHEMBL10237342 | 0.88 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL22613 | 0.86 | MEN1 (0.34) | CCNCCDK8 | |
| SCHEMBL10237351 | 0.85 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL29175 | 0.84 | CCNC (0.31) | CCNCCDK8 | |
| SCHEMBL15031460 | 0.84 | CCNC (0.31) | CCNCCDK8 | |
| SCHEMBL10237460 | 0.84 | KDM4E (0.38) | CCNCCDK8DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MERCK SHARP & DOHME LLC | 2012-05-10 | — | — | US | disclosed |
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MERCK SHARP & DOHME LLC | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MTOR, RICTOR, RPTOR | CCNC 1911/4885CDK8 408/4885DGAT1 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.